4
Changes in Ownership
MYRIAD GENETICS INC Filed Acc 0001219036-21-000012
Chief Scientific Officer sold 6,812 shares at an average $32.39 ($220,608)
- Chief Scientific Officer acquired 6,812 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
LANCHBURY JERRY S · Chief Scientific Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-06-28 | Exercise or conversion : show line 1 in the form | +3,973 | $26.49 | $105,245 | 236,523 | D |
| 2021-06-28 | Sale : show line 2 in the form | −3,973 | $32.43 | $128,855 | 232,550 | D |
| 2021-06-28 | Exercise or conversion : show line 3 in the form | +1,891 | $26.49 | $50,093 | 234,441 | D |
| 2021-06-28 | Sale : show line 4 in the form | −1,891 | $32.23 | $60,950 | 232,550 | D |
| 2021-06-28 | Exercise or conversion : show line 5 in the form | +948 | $19.47 | $18,458 | 233,498 | D |
| 2021-06-28 | Sale : show line 6 in the form | −948 | $32.49 | $30,804 | 232,550 | D |
| Open-market sales · 6,812 sh · avg $32.39 · $220,608 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-06-28 | Exercise or conversion : show line 7 in the form Incentive Stock Option (right to buy) | −1,891 | 1,884 | D |
| 2021-06-28 | Exercise or conversion : show line 8 in the form Non-Qualified Stock Option (right to buy) | −948 | 17,692 | D |
| 2021-06-28 | Exercise or conversion : show line 9 in the form Non-Qualified Stock Option (right to buy) | −3,973 | 172,252 | D |
Loading xslF345X03/edgardoc.xml…